BioWorld - Thursday, December 14, 2023 Breaking News: Topic alerts now available for all BioWorld subscribers See today's BioWorld Science Home » Oral BBT-209 attenuates fibrosis in mouse model of IPF ...
Researchers from Hanmi Science Co. Ltd. presented preclinical data for the novel long-acting glucagon/GIP/GLP-1 triple agonist HM-15211, being evaluated as potential treatment of idiopathic pulmonary ...
Researchers reveal critical mechanism behind idiopathic pulmonary fibrosis. Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results